- World rank, all time
- #31,772 of 42,892
- Rank in France
- #1,779 of 2,321
- Research works
- 148 ▼ 27% vs 2013–17
- Citations
- 2.1k 14.3 per fractional work
- Top-10% rate
- 12.2% record average 16.5%
- Open access
- 20% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.2×. Every wedge is a field page.
- Medicine 3.2×
- Health Professions 2.5×
- Immunology and Microbiology 2.3×
- Nursing 1.9×
- Biochemistry, Genetics and Molecular Biology 1.5×
- Arts and Humanities 1.4×
- Neuroscience 0.8×
- Agricultural and Biological Sciences 0.6×
- Physics and Astronomy 0.6×
- Psychology 0.6×
- Economics, Econometrics and Finance 0.4×
- Social Sciences 0.4×
- Chemistry 0.4×
- Materials Science 0.3×
- Dentistry 0.2×
- Business, Management and Accounting 0.1×
- Engineering 0.1×
- Environmental Science 0.0×
Who are the top researchers at Groupe d'Oncologie Radiothérapie Tête et Cou?
Ranked on the composite score, J.C. Borderon lead among researchers whose main affiliation is Groupe d'Oncologie Radiothérapie Tête et Cou.
- 1 J.C. Borderon France · #1,584,073 worldwide 9 citations · 19 works
Which keywords describe research at Groupe d'Oncologie Radiothérapie Tête et Cou?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Epidemiology, Radiotherapy, Clinical Practice Guidelines, Survival, Prognostic Factors, Metastasis and Prognosis.
- Developmental Trauma
- Tissue of Origin
- Cancer of Unknown Primary
- Healthcare Quality Indicators
- Diagnostic Algorithm
- Breast Cancer
- Targeted Therapy
- Prevention
- Survival Analysis
- Immunohistochemistry
- Diagnosis
- Clinical Trials
- Surgical Management
- Nasopharyngeal Carcinoma
- Human Papillomavirus
- Prognosis
- Prognostic Factors
- Survival
- Clinical Practice Guidelines
- Chemotherapy
- Epidemiology
- Radiotherapy
- Inflammation
- Quality of Life
- Metastasis
- Squamous Cell Carcinoma
- Cetuximab
- Oropharyngeal Cancer
- Biomarkers
- Clinical Management
- Mental Health
- Molecular Profiling
- Neoadjuvant Therapy
- Social Determinants of Health
- Antimicrobial Resistance
- Gene Expression Profiling
- Surgery
- Molecular Classification
- Cultural History
- Antibiotic Prophylaxis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology20▲ 3.3×58 topics
- Chemotherapy15▲ 14×20 topics
- Radiotherapy12▲ 20×12 topics
- Clinical Practice Guidelines8▲ 9.6×10 topics
- Inflammation8▲ 2.2×28 topics
- Survival7▲ 36×3 topics
- Quality of Life7▲ 3.4×19 topics
- Prognostic Factors6▲ 9.5×13 topics
- Metastasis6▲ 12×5 topics
- Prognosis6▲ 13×6 topics
- Squamous Cell Carcinoma6▲ 44×3 topics
- Human Papillomavirus6▲ 31×2 topics
- Cetuximab6▲ 45×2 topics
- Nasopharyngeal Carcinoma5▲ 74×1 topic
- Oropharyngeal Cancer5▲ 74×1 topic
- Surgical Management5▲ 7.9×14 topics
- Biomarkers5▲ 5.7×11 topics
- Clinical Trials5▲ 5.3×9 topics
- Clinical Management5▲ 16×6 topics
- Diagnosis4▲ 2.9×18 topics
- Mental Health4▲ 2.6×5 topics
- Immunohistochemistry4▲ 28×4 topics
- Molecular Profiling4▲ 22×3 topics
- Survival Analysis4▲ 9.5×5 topics
- Neoadjuvant Therapy4▲ 11×5 topics
- Prevention4▲ 6.2×5 topics
- Social Determinants of Health4▲ 11×3 topics
- Targeted Therapy3▲ 11×5 topics
- Antimicrobial Resistance3▲ 8.7×7 topics
- Breast Cancer3▲ 7.9×8 topics
- Gene Expression Profiling3▲ 22×2 topics
- Diagnostic Algorithm3▲ 32×2 topics
- Surgery3▲ 6.0×6 topics
- Healthcare Quality Indicators3▲ 33×2 topics
- Molecular Classification3▲ 13×4 topics
- Cancer of Unknown Primary3▲ 48×1 topic
- Cultural History3▲ 12×4 topics
- Tissue of Origin3▲ 48×1 topic
- Antibiotic Prophylaxis2▲ 19×3 topics
- Developmental Trauma2▲ 53×1 topic
Which research topics does Groupe d'Oncologie Radiothérapie Tête et Cou publish most on?
By volume in 2022–2025: Head and Neck Cancer Studies, Uterine Myomas and Treatments, Linguistics and Language Studies and Bone fractures and treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Head and Neck Cancer Studies Otorhinolaryngology 0 works
- 2 Uterine Myomas and Treatments Obstetrics and Gynecology 0 works
- 3 Linguistics and Language Studies Language and Linguistics 0 works
- 4 Bone fractures and treatments Epidemiology 0 works
- 5 Trauma and Emergency Care Studies Emergency Medicine 0 works
- 6 Endometriosis Research and Treatment Reproductive Medicine 0 works
- 7 Hip and Femur Fractures Surgery 0 works
- 8 Gynecological conditions and treatments Obstetrics and Gynecology 0 works
- 9 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 10 Mast cells and histamine Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Groupe d'Oncologie Radiothérapie Tête et Cou's research output changed?
Output in 2018–2022 was 27% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tours
- Université de Tours
- Centre Hospitalier Universitaire de Tours
- Centre d'Etudes Supérieures de la Renaissance
- School of Business and Management
- CItés, Territoires, Environnement et Sociétés
- Laboratoire de Mathématiques et Physique Théorique
- Imaging, Brain, and Neuropsychiatry
- Thion Medical (France)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.